Nanotechnology will offer doctors new ways to diagnose and treat patients, boosting efficiency and slashing costs.

Newly developed techniques could propel a field already advancing rapidly to complement modern medicine.

Its screen for selected variants of some disease-linked genes gives customers an incomplete picture of their risk—do they know?

Microfluidic systems redefined biology by providing platforms that handle small fluid volumes, catalyzing advancements in cellular and molecular studies.

Microbes in the gut influence the death of support cells in the brain by producing isoamylamine, a study suggests.

The biotech company Verve Therapeutics launched the study with the aim of using base editing to treat a genetic condition that causes high cholesterol and increases a person's risk of developing cardiovascular disease.

The first wave of AI-driven job loss among doctors will be in the field of radiology and is poised to force a paradigm shift in medical imaging.

Many preclinical studies carried out in vivo are poorly designed and generate irreproducible data, but efforts to address the problem are on the rise.

Recent advances in modeling the human placenta, the least understood organ, may inform placental disorders like preeclampsia.